On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- Limited proteolysis vs. degradation
- Regulation of proteolytic activity (1)
- Regulation of proteolytic activity (2)
- Apoptotic pathway
- Caspase structure (1)
- Caspase structure (2)
- Caspase structure - the active site
- Caspase structure - zooming in the active site
- Caspase zymogen activation
- Monomer/dimer status of caspase zymogens
- Initiator and executioner caspases
- Natural caspase inhibitors
- CrmA
- Selectivity of CrmA
- p35
- Selectivity of p35
- p35 docks into active site of caspases
- CrmA and caspases active site
- Viral "suicide" caspase inhibitors
- IAPs - the endogenous caspase regulators
- Human IAPs (BIRC 1-8)
- Some other IAPs
- Mouse IAPs knockout phenotypes
- Multiple proposed IAP functions
- The BIR domain (1)
- The BIR domain (2)
- IAPs as caspase inhibitors - XIAP, the paradigm
- Domain organization of XIAP
- Caspase 3/BIR2 complex
- Structure of caspase 3/DEVD-CHO
- Structure of the caspase 3/BIR2 complex
- Inhibitor footprints and the role of the 381 loop
- Caspase-3 bound state
- Caspase-3 free state
- Two site interaction hypothesis
- BIR2 mechanism
- Comparison of XIAP-BIR complexes
- BIR3 mechanism
- XIAP inhibition of caspases
- Caspase activation vs. IAP derepression
- The SMAC groove...competition of IBMs
- IBMs
- SMAC mechanism - caspase 9/BIR3
- BIR domain topology
- BIR2 domain comparisons - the SMAC groove
- BIR2 domain comparisons - the N-terminal linker
- BIR3 domain comparisons - the SMAC groove
- BIR2 domain comparisons - the C-terminal helix
- Variations in N-terminal linker or C-terminal helix
- Human IAPs (BIRC 1-8)
- What about the other 7 human IAPs?
- Acknowledgements
- Representative reviews
Topics Covered
- Apoptosis
- Proteolytic mechanisms
- Caspases
- Activation mechanisms
- Natural caspase inhibitors
- Viral inhibitors
- IAPs
- Inhibitory mechanisms
- IAP antagonists
- Theory of activating apoptosis by de-repression of caspase inhibition
Talk Citation
Salvesen, G. (2007, October 1). Natural caspase inhibitors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/CXLK6356.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. Guy Salvesen has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.